Parkinson's Disease Clinical Trials

A listing of Parkinson's Disease medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study of Accordion Pill™ Carbidopa/Levodopa, Sinemet®, Placebo -AP-CD/LD and Placebo- Sinemet to evaluate Parkinson's Disease

Arizona

Phoenix Arizona 85004

A Phase 2 clinical study for patients with Parkinson's Disease

Phoenix Arizona 85004

Patients are needed to participate in a clinical research study of Accordion Pill™ Carbidopa/Levodopa, Sinemet®, Placebo -AP-CD/LD and Placebo- Sinemet to evaluate Parkinson's Disease

Scottsdale Arizona 85259

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Tucson Arizona

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Tucson Arizona

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

California

PAREXEL
Glendale California 91206

Patients are needed to participate in a Phase 1 clinical research study evaluating a potential new treatment for Parkinson's disease.

View More ▼

Fountain Valley California 92708

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Fountain Valley California 92708-5153

A Phase 2 clinical study for patients with Parkinson's Disease

Fountain Valley California 92708

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Fresno California 93710

A Phase 2 clinical study for patients with Parkinson's Disease

Fresno California 93710

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Fullerton California 92835

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Irvine California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Irvine California

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

La Jolla California 92037

A clinical study for patients with Parkinson's Disease

Loma Linda California 92354

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Long Beach California 90806

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Los Angeles California 90048

A clinical trial seeking patients for a research study for the treatment of Parkinson's Disease (EPI-589)

Los Angeles California 90033

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Los Angeles California 91403

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Mountain View California 94043

A clinical trial to evaluate treatments for patients with Parkinson's Disease

Pasadena California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Pasadena California 91105

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Pasadena California

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Reseda California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Reseda California 91335

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

San Diego California 92037

A clinical research study of BIIB054 and Placebo for the treatment of Parkinson's Disease

San Francisco California 94115

A clinical trial seeking patients for a research study for the treatment of Parkinson's Disease (EPI-589)

San Francisco California 94115

Patients are needed to participate in a clinical research study evaluating Activa PC+S for the treatment of Parkinson's Disease or Primary Dystonia

San Francisco California 94143

Patients are needed to participate in a clinical research study of AAV2-hAADC to evaluate Parkinson's Disease

San Francisco California 94121

Patients are needed to participate in a clinical research study of interventional MRI for implantation of DBS electrodes and DBS electrodes to evaluate Parkinson's Disease or Dystonia

Santa Ana California 92705

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Torrance California 90505

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Valencia California 91355

Patients are needed to participate in a clinical research study of Deep Brain Stimulation to evaluate Parkinson's Disease

Ventura California

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Ventura California

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Colorado

Aurora Colorado 80045

A clinical research study of cannabidiol and placebo for the treatment of Parkinson's Disease

Aurora Colorado 80045

Patients are needed to participate in a clinical research study of Accordion Pill™ Carbidopa/Levodopa, Sinemet®, Placebo -AP-CD/LD and Placebo- Sinemet to evaluate Parkinson's Disease

Boulder Colorado

A clinical trial to evaluate treatments using Amantadine ER Tablets and Placebo Tablets for patients with Parkinson's Disease or Levodopa Induced Dyskinesias (LID)

Boulder Colorado

Patients are needed to participate in a clinical research study of Amantadine HCl ER (ALLAY-LID II) and Placebo to evaluate Parkinson's Disease or Levodopa Induced Dyskinesia (LID)

Englewood Colorado 80113

A clinical trial to evaluate treatments using Activa PC+S for patients with Parkinson's Disease

View More ▼

Englewood Colorado 80113-2776

A Phase 2 clinical study for patients with Parkinson's Disease

Englewood Colorado 80113

Patients are needed to participate in a clinical research study evaluating Ropinirole Hydrochloride for the treatment of Parkinson's Disease

District of Columbia

Washington District of Columbia 20007

A Phase 3 clinical study for patients with Idiopathic Parkinson's Disease

Florida

Research Center
Miami Florida

A Phase 2, Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 Oral Solution in Patients with Parkinson's Disease of Moderate Severity Responding to Immediate-Release Oral Levodopa/Carbidopa and Withdrawn from Levodopa/Carbidopa

Research Center
Orlando Florida

A Phase 2, Two-Part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SAGE-217 Oral Solution in Patients with Parkinson's Disease of Moderate Severity Responding to Immediate-Release Oral Levodopa/Carbidopa and Withdrawn from Levodopa/Carbidopa

Palm Beach Neurological Center
Palm Beach Gardens Florida 33410

A Phase 3, Randomized , Double Blind, Placebo controlled Study. Investigating the Efficacy and Safety of CVT-301 (Levodopa inhalation Powder) in Parkinson's Disease With Motor Response Fluctuations (Off Phenomena)

University of South Florida - USF Health Byrd Alzheimer's Institute
Tampa Florida 33613

A 15-week, Phase 2, Double Blind, Randomized, Placebo-controlled, Flexible Dose Study To Investigate The Efficacy, Safety And Tolerability Of Pf-06649751 In Subjects With Early Stage Parkinson's Disease

University of South Florida - Morsani Center for Advanced Healthcare
Tampa Florida 33612

A 15-week, Phase 2, Double Blind, Randomized, Placebo-controlled, Flexible Dose Study To Investigate The Efficacy, Safety And Tolerability Of Pf-06649751 In Subjects With Early Stage Parkinson's Disease